Bruker Co. (NASDAQ:BRKR) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Bruker Co. (NASDAQ:BRKR) has been given a consensus recommendation of “Moderate Buy” by the ten analysts that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $81.40.

BRKR has been the topic of a number of research reports. Citigroup decreased their price target on Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. Wells Fargo & Company started coverage on Bruker in a report on Tuesday, August 27th. They set an “overweight” rating and a $78.00 price objective on the stock. TD Cowen cut their target price on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a report on Wednesday, August 7th. The Goldman Sachs Group dropped their price objective on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. Finally, Jefferies Financial Group started coverage on shares of Bruker in a report on Monday, June 3rd. They issued a “buy” rating and a $85.00 price target for the company.

Institutional Trading of Bruker

Several large investors have recently added to or reduced their stakes in the company. TD Asset Management Inc raised its stake in shares of Bruker by 7.4% in the 1st quarter. TD Asset Management Inc now owns 1,788,763 shares of the medical research company’s stock valued at $168,036,000 after acquiring an additional 123,984 shares in the last quarter. Lighthouse Investment Partners LLC bought a new stake in Bruker in the fourth quarter valued at $3,366,000. Nomura Holdings Inc. acquired a new stake in shares of Bruker during the 4th quarter worth about $5,593,000. Iron Triangle Partners LP increased its holdings in shares of Bruker by 4.4% during the fourth quarter. Iron Triangle Partners LP now owns 450,000 shares of the medical research company’s stock worth $33,066,000 after buying an additional 19,157 shares in the last quarter. Finally, Congress Wealth Management LLC DE increased its holdings in Bruker by 21.8% during the 1st quarter. Congress Wealth Management LLC DE now owns 162,191 shares of the medical research company’s stock valued at $15,236,000 after purchasing an additional 29,029 shares in the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Bruker Stock Up 2.7 %

Bruker stock opened at $66.80 on Thursday. The company has a market cap of $9.71 billion, a PE ratio of 24.29, a PEG ratio of 2.31 and a beta of 1.18. Bruker has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The business’s 50-day simple moving average is $64.30 and its two-hundred day simple moving average is $73.12. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.75 and a current ratio of 1.65.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, meeting analysts’ consensus estimates of $0.52. The business had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business’s revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.50 earnings per share. Equities analysts anticipate that Bruker will post 2.61 EPS for the current year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Monday, September 2nd were given a dividend of $0.05 per share. The ex-dividend date was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.30%. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.